{"id":"6af3ca50-1181-4939-9c18-8de1a2069584","kind":"news","code":"6af3ca50-1181-4939-9c18-8de1a2069584","name":"Tushenzhihe raises an undisclosed amount in equity transfer","nameBasis":"translated-title","summary":"On 2026-07-31, according to Xiniu Data, Tushenzhihe completed equity transfer for an undisclosed amount. Investors were Shanghai Juchaohan Management Consulting Partnership (Limited Partnership). The company is an AI protein design services provider.","description":"","country":null,"category":null,"originalName":"途深智合完成股权转让融资，金额金额未披露","eventDate":"2026-07-31T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-18T16:54:21.135Z","englishUpdatedAt":"2026-10-20T18:21:37.466Z","reviewedAt":"2026-10-20T18:21:37.466Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"445a019fc557404cce3be81e6607f8bf712801841326588054c068a235b2e8af","companyId":"e87a35bd-374a-4173-a5e0-a6c1f395d3ba","foundedYear":null,"logoUrl":null,"originalText":"2026年7月31日，据烯牛数据报道，途深智合完成股权转让融资，金额未披露。投资方为上海聚超晗管理咨询合伙企业（有限合伙）。该公司为AI蛋白质设计服务商。","sources":[],"related":[{"id":"5fbb90ad-e8e5-4ae5-8029-5709fb24247e","kind":"institutions","code":"UB-I8599","name":"Shanghai Juchaohan Management Consulting Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Shanghai Juchaohan Management Consulting Partnership (Limited Partnership), an early-stage venture capital firm focused on technology.","description":"Shanghai Juchaohan Management Consulting Partnership (Limited Partnership), an early-stage venture capital firm focused on technology.","country":null,"category":null,"originalName":"上海聚超晗管理咨询合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:25.810Z","englishUpdatedAt":"2026-10-15T17:35:39.096Z","reviewedAt":"2026-10-15T17:35:39.096Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d72332ca5324a1cc9d4d3b7454d0289db08d6bf555140af2bfb3746b6ed88a12","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shanghai-juchaohan-management-consulting-partnership-limited-partnership"},{"id":"e87a35bd-374a-4173-a5e0-a6c1f395d3ba","kind":"companies","code":"UB-C1680","name":"Tushenzhihe","nameBasis":"transliterated","summary":"The company develops lightweight, controllable AI protein design models to reduce the difficulty, development time, and cost of new synthetic biological products and drugs","description":"The company develops lightweight, controllable AI protein design models to reduce the difficulty, development time, and cost of new synthetic biological products and drugs","country":"China","category":null,"originalName":"途深智合","eventDate":null,"website":"https://tsynbio.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:42.661Z","reviewedAt":"2026-10-20T18:26:42.661Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"cfed7e3eb1d7749965546d2aac9c15e89e094b1fe1a4576527b67ec3fbc482a0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/tushenzhihe"}],"path":"/news/6af3ca50-1181-4939-9c18-8de1a2069584","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Tushenzhihe","path":"/companies/tushenzhihe"}},"canonical":"https://uniquebase.ai/news/6af3ca50-1181-4939-9c18-8de1a2069584"}